Clinical Trial Update: Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Malignancies or Secondary Myelodysplasia Previously Treated With High-Dose Chemotherapy and Autologous Stem Cell Transplant [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating donor stem cell transplantation for patients with relapsed hematologic malignancies or secondary myelodysplasia who had prior high-dose…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Lymphoma
• Lymphoproliferative Disorder
• Multiple Myeloma
• Myelodysplastic Myeloproliferative Neoplasms
• Myelodysplastic Syndromes
• Plasma Cell Neoplasm

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Leukemia, Lymphoma | Phase 2 | Status: TERMINATED | Results posted: 2017-03-24